NO20092131L - Fettsyrealkoholer - Google Patents
FettsyrealkoholerInfo
- Publication number
- NO20092131L NO20092131L NO20092131A NO20092131A NO20092131L NO 20092131 L NO20092131 L NO 20092131L NO 20092131 A NO20092131 A NO 20092131A NO 20092131 A NO20092131 A NO 20092131A NO 20092131 L NO20092131 L NO 20092131L
- Authority
- NO
- Norway
- Prior art keywords
- prodrugs
- fatty alcohols
- omega
- relates
- polyunsaturated alcohols
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Den foreliggende oppfinnelsen vedrører et lipidpreparat som omfatter minst omega-3 flenimettede alkoholer, eller prodrugs derav, der de omega-3 flenimettede alkoholer, eller prodmgs derav, omfatter minst (all-Z)-5,8,ll,14,17-eicosapentaen-1 -ol, eller prodrugs derav, og (all-Z)-4,7,10,13,16,19-docosaheksaen-l-ol, eller prodrugs derav, og deres anvendelse som et legemiddel, i særdeleshet forbehandling av forhøyede triglyceridnivåer. Oppfinnelsen vedrører fremgangsmåter for fremstilling av disse prodrugs fra marine oljer.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85626906P | 2006-11-03 | 2006-11-03 | |
US85626806P | 2006-11-03 | 2006-11-03 | |
US85626706P | 2006-11-03 | 2006-11-03 | |
SE0602352 | 2006-11-03 | ||
PCT/IB2007/004590 WO2008139261A2 (en) | 2006-11-03 | 2007-11-02 | Omega-3 lipid compound |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092131L true NO20092131L (no) | 2009-06-30 |
Family
ID=39876685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092131A NO20092131L (no) | 2006-11-03 | 2009-06-02 | Fettsyrealkoholer |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100266681A1 (no) |
JP (1) | JP2010509204A (no) |
KR (1) | KR20090077081A (no) |
CN (1) | CN101646426A (no) |
BR (1) | BRPI0718393A2 (no) |
CA (1) | CA2667153A1 (no) |
MX (1) | MX2009004339A (no) |
NO (1) | NO20092131L (no) |
RU (1) | RU2009121007A (no) |
WO (1) | WO2008139261A2 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009134147A1 (en) * | 2008-05-02 | 2009-11-05 | Pronova Biopharma Norge As | Lipid compositions containing derivatives of epa and dha an their use thereof |
GB201009368D0 (en) * | 2010-06-04 | 2010-07-21 | Sana Pharma As | Dietary formulations |
JP5271454B2 (ja) * | 2010-09-01 | 2013-08-21 | 日本水産株式会社 | アルコール性障害緩和剤 |
WO2013188417A2 (en) | 2012-06-11 | 2013-12-19 | The Cleveland Clinic Foundation | Treatment and prevention of cardiovascular disease and thrombosis |
CN102860506A (zh) * | 2012-08-08 | 2013-01-09 | 辽宁省大连海洋渔业集团公司 | 磷虾油微囊粉及其制备方法 |
ES2619714T3 (es) * | 2013-02-28 | 2017-06-26 | Pronova Biopharma Norge As | Método de preparar ácido 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaeniloxi)butanoico |
EP2826384A1 (de) | 2013-07-16 | 2015-01-21 | Evonik Industries AG | Verfahren zur Trocknung von Biomasse |
BR112017005388B1 (pt) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | Alimento para animais contendo biomassa de aurantiochytrium |
ES2873094T3 (es) | 2014-10-02 | 2021-11-03 | Evonik Operations Gmbh | Procedimiento para la producción de un pienso que contiene PUFAs mediante extrusión de una biomasa que contiene PUFAs de tipo Labyrinthulomycetes |
WO2016050552A1 (de) | 2014-10-02 | 2016-04-07 | Evonik Degussa Gmbh | Verfahren zur herstellung einer pufas enthaltenden biomasse mit hoher zellstabilität |
BR112017006833B1 (pt) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | Alimento para animais contendo ácido graxo poli-insaturado e processo para produzir o mesmo |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01207224A (ja) * | 1988-02-10 | 1989-08-21 | Nonogawa Shoji:Kk | 頭髪用化粧料及び養毛剤 |
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
EP1121928B1 (en) * | 2000-01-31 | 2008-01-23 | Härting S.A. | Compositions containing phytosterol and policosanol esters of fatty acids for reducing blood cholesterol and triglycerides |
ES2223924T3 (es) * | 2000-09-21 | 2005-03-01 | Nutrition 21, Inc. | Composiciones que contienen cromo para el tratamiento de la diabetes, la reduccion de la grasa corporal, la mejora de la sensibilidad a la insulina, la reduccion de la hiperglicemia y la reduccion de la hipercolesteremia. |
DK1997498T3 (da) * | 2001-06-18 | 2012-07-30 | Neptune Technologies & Bioressources Inc | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
ITMI20012384A1 (it) * | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
CA2485116C (en) * | 2002-05-03 | 2013-02-05 | Pronova Biocare As | Use of epa and dha in secondary prevention |
KR100951758B1 (ko) * | 2002-08-07 | 2010-04-08 | 가오 가부시키가이샤 | 유지 조성물 |
US8017651B2 (en) * | 2002-11-22 | 2011-09-13 | Bionexus, Ltd. | Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
WO2004078166A2 (en) * | 2003-03-05 | 2004-09-16 | Solvay Pharmaceuticals Gmbh | Use of omega-3-fatty acids in the treatment of diabetic patients |
SE0303513D0 (sv) * | 2003-12-19 | 2003-12-19 | Pronova Biocare As | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
-
2007
- 2007-11-02 CN CN200780040625A patent/CN101646426A/zh active Pending
- 2007-11-02 JP JP2009535151A patent/JP2010509204A/ja active Pending
- 2007-11-02 MX MX2009004339A patent/MX2009004339A/es not_active Application Discontinuation
- 2007-11-02 WO PCT/IB2007/004590 patent/WO2008139261A2/en active Application Filing
- 2007-11-02 RU RU2009121007/04A patent/RU2009121007A/ru not_active Application Discontinuation
- 2007-11-02 CA CA002667153A patent/CA2667153A1/en not_active Abandoned
- 2007-11-02 US US12/447,971 patent/US20100266681A1/en not_active Abandoned
- 2007-11-02 KR KR1020097011471A patent/KR20090077081A/ko not_active Application Discontinuation
- 2007-11-02 BR BRPI0718393-3A patent/BRPI0718393A2/pt not_active IP Right Cessation
-
2009
- 2009-06-02 NO NO20092131A patent/NO20092131L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008139261A2 (en) | 2008-11-20 |
JP2010509204A (ja) | 2010-03-25 |
CA2667153A1 (en) | 2008-11-20 |
RU2009121007A (ru) | 2010-12-10 |
US20100266681A1 (en) | 2010-10-21 |
WO2008139261A9 (en) | 2009-11-12 |
BRPI0718393A2 (pt) | 2013-11-26 |
KR20090077081A (ko) | 2009-07-14 |
CN101646426A (zh) | 2010-02-10 |
MX2009004339A (es) | 2009-05-20 |
WO2008139261A3 (en) | 2009-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092131L (no) | Fettsyrealkoholer | |
DK2436275T3 (da) | Lipidsammensætning til forbedring af hjernefunktion | |
WO2008036353A3 (en) | Omega-3 diglyceride emulsions | |
ECSP11010746A (es) | Salicilatos acetilados con ácidos grasos y sus usos | |
NZ595599A (en) | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof | |
NI201200038A (es) | Conjugados de niacina y ácidos grasos y sus usos | |
MY152880A (en) | Use of dpa(n-6) oils in infant formula | |
BR112012020666A2 (pt) | "composições de óleo de ácido esteraridônico" | |
GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
DK2007214T3 (da) | Spiselige produkter med lavt indhold af mættede og trans-umættede fedter | |
BR112018005976A2 (pt) | óleos de triglicerídeo tendo moléculas de triglicerídeo assimétricas | |
FR2955459B1 (fr) | Composition huileuse riche en monoglycerides de dha | |
PH12018500410A1 (en) | Refined oil compositions and methods for making | |
BRPI0917942A2 (pt) | Óleo contendo um ou mais fosfolipídeos de ácidos graxos poli-insaturados de cadeia longa derivados de biomassa. | |
DOP2007000029A (es) | Composiciones antimicóticas de ramnolípidos y métodos relacionados con su uso | |
DOP2007000028A (es) | Composiciones de ramnolípidos y métodos relacionados con su uso | |
AR055659A1 (es) | Composicion fungicida | |
BRPI0413491A (pt) | sistema de gordura vegetal hidrogenada | |
BR112018009288A8 (pt) | composições de triglicerídeos de cadeia média | |
BR112015001616B8 (pt) | Método para aumento do teor de sus em um óleo ou em uma fração de oleína por intraesterificação 1,3-específica, óleo ou oleína intraesterificado 1,3-seletivo e seu uso | |
CO6390033A2 (es) | Ácido graso pliinsaturado y éster de diol como agente anti-acné | |
MX2011010935A (es) | Composicion basada en petrolato comprendido mas de 10%de silicon para sensacion mejorada al tiempo que permanece estable. | |
MX2011007188A (es) | Metodos para incrementar niveles de plasmalogenos endogenos. | |
BRPI0410854A (pt) | sistema de gordura vegetal hidrogenada | |
WO2007135518A3 (en) | Use of choline-based preparations for the treatment of tinnitus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |